119 related articles for article (PubMed ID: 38213161)
1. Molecular Targets and Mechanisms of Hedyotis diffusa Willd. for Esophageal Adenocarcinoma Treatment Based on Network Pharmacology and Weighted Gene Co-expression Network Analysis.
Zhuang Y; Sun YG; Wang CG; Zhang Q; Che C; Shao F
Curr Drug Targets; 2024 Jan; ():. PubMed ID: 38213161
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Therapeutic Mechanism of Hedyotis Diffusa Willd (HDW)‒ Scutellaria Barbata (SB) in Clear Cell Renal Cell Carcinoma
Bai Y; Chen R; Sun J; Guo Y
Comb Chem High Throughput Screen; 2024; 27(6):910-921. PubMed ID: 37526191
[TBL] [Abstract][Full Text] [Related]
3. Network pharmacology and experimental validation to identify the potential mechanism of Hedyotis diffusa Willd against rheumatoid arthritis.
Deng H; Jiang J; Zhang S; Wu L; Zhang Q; Sun W
Sci Rep; 2023 Jan; 13(1):1425. PubMed ID: 36697436
[TBL] [Abstract][Full Text] [Related]
4. Investigating the Multi-Target Pharmacological Mechanism of
Song Y; Wang H; Pan Y; Liu T
Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31600936
[No Abstract] [Full Text] [Related]
5. Hedyotis diffusa Willd and Astragalus membranaceus May Exert Anti-colon Cancer Effects by Affecting AKTI Expression, as Determined by Network Pharmacology and Molecular Docking.
Ren J; Mo Z; Huang Z; Li S
Curr Comput Aided Drug Des; 2024 Apr; ():. PubMed ID: 38638040
[TBL] [Abstract][Full Text] [Related]
6. Identification of Hedyotis diffusa Willd-specific mRNA-miRNA-lncRNA network in rheumatoid arthritis based on network pharmacology, bioinformatics analysis, and experimental verification.
Jiang J; Huang M; Zhang SS; Wu YG; Li XL; Deng H; Qili XY; Chen JL; Meng Y; Sun WK
Sci Rep; 2024 Mar; 14(1):6291. PubMed ID: 38491124
[TBL] [Abstract][Full Text] [Related]
7. Exploring the mechanism of action of Hedyotis diffusa Willd on acne using network analysis.
Seo G; Kim K
Medicine (Baltimore); 2023 Mar; 102(12):e33323. PubMed ID: 36961163
[TBL] [Abstract][Full Text] [Related]
8. The protective capability of
Li Y; Ding T; Chen J; Ji J; Wang W; Ding B; Ge W; Fan Y; Xu L
Front Immunol; 2022; 13():943827. PubMed ID: 35958622
[TBL] [Abstract][Full Text] [Related]
9. Network pharmacology prediction and experiment validation of anti-liver cancer activity of Curcumae Rhizoma and Hedyotis diffusa Willd.
Tie S; Tong T; Zhan G; Li X; Ouyang D; Cao J
Ann Med Surg (Lond); 2024 Jun; 86(6):3337-3348. PubMed ID: 38846818
[TBL] [Abstract][Full Text] [Related]
10. The anti-inflammatory effects of Hedyotis diffusa Willd on SLE with STAT3 as a key target.
Xu L; Li Y; Ji J; Lai Y; Chen J; Ding T; Li H; Ding B; Ge W
J Ethnopharmacol; 2022 Nov; 298():115597. PubMed ID: 35940466
[TBL] [Abstract][Full Text] [Related]
11. Network pharmacology and experimental verification study on the mechanism of Hedyotis diffusa Willd in treating colorectal cancer.
Yuan X; Huang H; Yu C; Tang Z; Li Y
Naunyn Schmiedebergs Arch Pharmacol; 2024 Mar; ():. PubMed ID: 38446216
[TBL] [Abstract][Full Text] [Related]
12. Network Pharmacology-Based Approach to Investigate the Mechanisms of
Liu X; Wu J; Zhang D; Wang K; Duan X; Meng Z; Zhang X
Evid Based Complement Alternat Med; 2018; 2018():7802639. PubMed ID: 29853970
[TBL] [Abstract][Full Text] [Related]
13. A Network Pharmacology Approach to Uncover the Multiple Mechanisms of
Liu X; Wu J; Zhang D; Wang K; Duan X; Zhang X
Evid Based Complement Alternat Med; 2018; 2018():6517034. PubMed ID: 29619072
[TBL] [Abstract][Full Text] [Related]
14. Network Pharmacology Analysis and Experimental Verification on Antiangiogenesis Mechanism of
Wu H; Zhang L; Wang C; Li F; Qi L; Xiao L; Zhang M; Zhang H; Zhang G; Qin Y
Evid Based Complement Alternat Med; 2023; 2023():1416841. PubMed ID: 36647454
[TBL] [Abstract][Full Text] [Related]
15. Protective Effect of
Wang X; Zhao J; Zhang R; Liu X; Ma C; Cao G; Wei Y; Yang P
Drug Des Devel Ther; 2022; 16():1995-2015. PubMed ID: 35783199
[TBL] [Abstract][Full Text] [Related]
16. The anti-tumor effect and bioactive phytochemicals of Hedyotis diffusa willd on ovarian cancer cells.
Zhang L; Zhang J; Qi B; Jiang G; Liu J; Zhang P; Ma Y; Li W
J Ethnopharmacol; 2016 Nov; 192():132-139. PubMed ID: 27426510
[TBL] [Abstract][Full Text] [Related]
17. [Effect of "Hedyotis Diffusae Herba-Smilacis Glabrae Rhizoma" in treatment of lung adenocarcinoma based on network pharmacology].
Li JL; Hou W
Zhongguo Zhong Yao Za Zhi; 2021 Dec; 46(23):6261-6270. PubMed ID: 34951253
[TBL] [Abstract][Full Text] [Related]
18. Exploring the mechanisms of anti-ovarian cancer of Hedyotis diffusa Willd and Scutellaria barbata D. Don through focal adhesion pathway.
Xu X; Chen F; Zhang L; Liu L; Zhang C; Zhang Z; Li W
J Ethnopharmacol; 2021 Oct; 279():114343. PubMed ID: 34147618
[TBL] [Abstract][Full Text] [Related]
19. [Mechanism of "Scutellaria barbata-Hedyotis diffusa" against breast cancer based on network pharmacology].
Jing XU; Feng-Qin S; Ke-Xin DU; Jia D; Dong-Yun LI
Zhongguo Zhong Yao Za Zhi; 2020 Sep; 45(18):4448-4454. PubMed ID: 33164375
[TBL] [Abstract][Full Text] [Related]
20.
Huang L; Xu H; Wu T; Li G
Evid Based Complement Alternat Med; 2021; 2021():5210152. PubMed ID: 34527062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]